Company / Operating Cash Flow per Share
Alkermes plc Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.14
FY2025
5-year range
$0.13 / $3.14
FY2021-FY2025
Trend
+16.1%
vs FY2024
Sector context
#33 of 212
Health Care
What the data says
Alkermes plc's operating cash flow per share of $3.14 is higher than 84% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has increased for 3 consecutive years, from $0.13 in FY2022 to $3.14 in FY2025.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of +43.3%. Top quartile in the Health Care sector.
Improved from $2.40 to $3.14 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +190.7%
- 5-Year CAGR
- +43.3%
- 10-Year CAGR
- -
Sector benchmark
+121.4% above sector average
Key checks
Key Insights
- Alkermes plc's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 16.1% year-over-year.
- Ranks #33 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | +16.1% |
| FY2024 | $2.71 | +12.7% |
| FY2023 | $2.40 | +1777.5% |
| FY2022 | $0.13 | -79.6% |
| FY2021 | $0.63 | +20.7% |
| FY2020 | $0.52 | +13.9% |
| FY2019 | $0.46 | -28.3% |
| FY2018 | $0.64 | +411.6% |
| FY2017 | $0.12 | +129.4% |
| FY2016 | -$0.42 | -142.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026